Clinical Trial Update: An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia. [NA]

View source ↗

Summary

An exploratory, double-arm, 8-week study assessed the feasibility and acceptability of abbreviated CT-156 treatment in adults with schizophrenia. The trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• CT-156 (CT-156)

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Schizophrenia | NA | Status: COMPLETED